Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut-based ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...

A federal bankruptcy court on November 18 formally approved Purdue’s $7.4 billion Chapter 11 plan to settle thousands of opioid-related lawsuits. The plan requires (1) a $6.5 billion contribution from ...

Purdue Pharma begins several days of hearings Wednesday to finalize a $7.4 billion bankruptcy restricting plan that no longer fully protects the company’s owners, members of the Sackler families, from ...

All 50 states agreed Monday to sign a settlement with Purdue Pharma, the company behind the highly addictive opioid Oxycontin, accepting $7.4 billion in payouts and prohibiting the Sackler family ...

The state of Connecticut will get $64 million from Purdue Pharma and the Sackler family for their role in the opioid crisis. It’s part of a $7.4 billion settlement announced by the U.S. Bankruptcy ...

Since Purdue Pharma filed for bankruptcy in 2019, Yoder's involvement in the proceedings has amounted to a de facto second job. Her responsibilities have included attending a number of court hearings, ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A federal judge on Wednesday allowed Purdue ...

The $7.5 billion opioid settlement involving Purdue Pharma took a major step forward Nov. 14 after the U.S. Bankruptcy Court for the Southern District of New York said it will confirm the company’s ...